SSSnita Sinukumar

Snita Sinukumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Snita Sinukumar has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Deepika S.

    Department of Surgical Oncology, MVR Cancer Centre and Research Institute, Calicut, India

    1 shared publication
  • Dileep Damodaran

    Department of Surgical Oncology, MVR Cancer Centre and Research Institute, Calicut, India

    1 shared publication
  • Sanjay Piplani

    Department of Surgical oncology, Jehangir Hospital, Pune, India

    1 shared publication

Latest Publications

  • Open Access

    Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

    by Snita Sinukumar, Dileep Damodaran, Deepika S., Sanjay Piplani

    Objective: To determine the best possible value of pathological PCI (pPCI) as a prognostic marker for survival in high-grade serous epithelial ovarian cancer patients in patients treated with neoadjuvant chemotherapy and interval cytoreductive surgery.Methods: All patients with FIGO stage IIIC high-grade serous ovarian carcinoma were included. Receiver operating curves (ROC) were used to determine the best possible score for pPCI in predicting survival. Survival curves were calculated using the Kaplan–Meier test, and factors affecting survival were compared using the log-rank test.Results: From January 2018 to January 2024, 171 patients who underwent interval cytoreductive surgery were included. Complete cytoreduction was achieved in 88% of the patients. ROC curves determined a (pPCI) cut-off value of 8 as the best possible score for predicting survival with a sensitivity of 82% and specificity of 67% (Youden’s Index = 0.60). pPCI with a cut-off value of 8 showed improved OS (p = 0.002) and DFS, (p = 0.001) in both univariate and multivariate analyses.Conclusion: Following interval cytoreductive surgery, despite optimal complete cytoreductive surgery, a pathological PCI of 8 is a poor prognostic indicator of survival and may serve as a surrogate clinical marker for guiding clinicians in adjuvant treatment, especially in resource-driven settings in the real world.